*Kuwa Health offers access to compounded medications, which are made in State Board of Pharmacy licensed 503(a) Compounding Pharmacies, or 503(b) Outsourcing Facilities. Compounded medications do not undergo pre-market review and are not FDA-approved. Risks, benefits, side-effects, and results may differ from FDA-approved medications, and the processes by which compounded medications are made have not been reviewed by the FDA. Kuwa Health does not offer the following FDA-approved medications: Rybelsus, Ozempic, Wegovy, Zepbound or Mounjaro. If you wish to receive one of these products, speak to your local healthcare provider. Novo Nordisk Inc. is the only company in the United States with FDA-approved products containing semaglutide, identified under the trade names Rybelsus, Ozempic, and Wegovy. Novo Nordisk Inc. does not sell semaglutide to any entities for use in compounding. Eli Lilly and Company is the only company in the United States with FDA-approved products containing tirzepatide, identified under the trade names Zepbound and Mounjaro. Eli Lilly and Company does not sell tirzepatide to any entities for use in compounding.

Refund policy: The initial consultation is free so you can explore our services with no obligation. Once you decide to move forward with a paid consultation or treatment plan, all fees are non-refundable. This ensures we can dedicate the necessary time and resources to your care. Exceptions will only be made in cases of billing errors or duplicate charges.